Browse the detailed record of transactions filed by Reardon Andrew. Insider active across 1 company, notably Ligand Pharmaceuticals INC. Cumulatively, 49 disclosures have been published. Split: 0 buy · 27 sells. Total volume traded: €3.6m. Activity tracked since 30 November 2022. The latest transaction was disclosed on 3 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Reardon Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Reardon Andrew has filed 38 disclosures in total. Across the 38 sampled filings, all concerning Ligand Pharmaceuticals INC, the transactions recorded between 2022-12-01 and 2026-07-06 are sales, with total sales of EUR 2363425 and no purchases.